Skip to main content
Cureus logoLink to Cureus
. 2024 Dec 4;16(12):e75090. doi: 10.7759/cureus.75090

Stuck in the Sump: A Rare Complication of Biliary Surgery

Daniel F Wagner 1,, Leanne Sowunmi 1, Ross Driscoll 1
Editors: Alexander Muacevic, John R Adler
PMCID: PMC11697999  PMID: 39759614

Abstract

Sump syndrome is a rare complication of biliary surgery that is now rarely seen in the era of Endoscopic Retrograde Cholangiopancreatography (ERCP). It occurs when the distal common bile duct becomes obstructed between an anastomosis from a choledochoduodenostomy (CDD) and the ampulla of Vater, forming a sump that accumulates debris. Sump syndrome should be considered as a diagnosis in patients who present with cholangitis or pancreatitis and any history of biliary diversion, regardless of the time of presentation. We report a 61-year-old female who presented with sump syndrome two years after undergoing a side-to-side CDD.

Keywords: biliary complication, case report, cholangitis, cholecystectomy, choledochoduodenostomy, mrcp, sump syndrome

Introduction

Sump syndrome is a rare complication of biliary surgery, mainly choledochoduodenostomy (CDD) or choledochojejunostomy, that is now rarely seen in the Endoscopic Retrograde Cholangiopancreatography (ERCP) era, with a reported prevalence of between 0 - 9.6% [1,2]. The CDD procedure may be performed when the common bile duct (CBD) drains improperly and has many indications, including strictures or obstruction of the bile duct and pancreas, biliary fistulas, recurrent bile duct stones, stenosis of the sphincter of Oddi, and choledochal cysts [2,3].

Classically, in sump syndrome, the distal bile duct becomes obstructed after CDD, with the CBD segment between the anastomosis and the ampulla of Vater becoming a reservoir or sump. This likely occurs due to low filling pressure in the distal bile duct because the well-functioning anastomosis interferes with normal distal peristalsis and drainage. When debris accumulates in the sump, recurrent pain episodes, fever, cholangitis, pancreatitis, biliary obstruction, or hepatic abscesses may develop [4].

We present the case of a 61-year-old female patient who exhibited clinical signs concerning for ascending cholangitis. Her detailed medical history, imaging studies, and ERCP led to the diagnosis of sump syndrome. This case was previously presented as a meeting abstract at the 2024 Michigan Chapter of the American College of Physicians Annual Scientific Meeting on October 26, 2024.

Case presentation

A 61-year-old female with a reported history of cholecystectomy, type 2 diabetes, and alcohol use disorder presented to the emergency department with two weeks of right-sided abdominal pain, nausea, and anorexia. She was hypertensive with right upper quadrant tenderness on physical exam. Her lab studies (Table 1) revealed elevated alkaline phosphatase (147 U/L) with otherwise normal transaminases, elevated lipase (1620 U/L), total hyperbilirubinemia (1.6 mg/dL), leukocytosis with a left shift (WBC 17.9/L), hyperglycemia (596 mg/dL), high anion gap metabolic acidosis (venous pH 7.14, CO2 7 mmol/L, anion gap 31 mmol/L. A computed tomography (CT) scan of her abdomen with contrast (Figures 1-2) showed abnormal appearing thick-walled proximal small bowel and a malrotated duodenum with surrounding inflammatory changes extending to the pancreas suspicious of fistulous communication to the bile ducts where there was extensive pneumobilia. She received fluids, ceftriaxone, metronidazole, and insulin and was transferred to our hospital.

Table 1. Blood test results from initial emergency department visit.

Glucose, blood urea nitrogen, anion gap, alkaline phosphatase, lipase, total bilirubin, white blood cell count, absolute neutrophil count (ANC), and beta-hydroxybutyrate were elevated (H). Sodium, potassium, chloride, CO2, and venous pH were low (L). 

Parameters Value Reference Range
Glucose 596 mg/dL (H) 70 – 99 mg/dL
Blood urea nitrogen 47 mg/dL (H) 8 – 23 mg/dL
Creatinine 0.94 mg/dL 0.60 – 1.10 mg/dL
Sodium 118 mmol/L (L) 135 – 145 mmol/L
Potassium 3.3 mmol/L (L) 3.5 – 5.3 mmol/L
Chloride 80 mmol/L (L) 98 – 108 mmol/L
CO2 7 mmol/L (L) 23 – 32 mmol/L
Anion gap 31 mmol/L (H) 7 – 16 mmol/L
Aspartate aminotransferase 10 U/L 0 – 37 U/L
Alanine aminotransferase 15 U/L 6 – 37 U/L
Alkaline phosphatase 147 U/L (H) 35 – 117 U/L
Lipase 1620 U/L (H) 16 – 63 U/L
Bilirubin, total 1.6 mg/dL (H) 0.0 – 1.2 mg/dL
White blood cell 17.1 10*9/L (H) 4.0 – 11.0 10*9/L
Neutrophils (ANC) absolute 14.8 10*9/L (H) 1.1 – 6.1 10*9/L
Hemoglobin 15.1 g/dL 12 – 16 g/dL
Platelets 194 10*9/L 140 – 440 10*9/L
pH, Venous 7.14 (L) 7.32 – 7.42
Beta-hydroxybutyrate 8.38 mmol/L (H) 0.02 – 0.27 mmol/L

Figure 1. Axial computed tomography (CT) abdomen/pelvis with contrast.

Figure 1

Arrow points to the pneumobilia.

Figure 2. Coronal computed tomography (CT) abdomen/pelvis with contrast.

Figure 2

Arrow points to a malrotated duodenum in the right upper quadrant of the abdomen.

Her complete medical record was obtained following her arrival at our facility and revealed that she had undergone an open cholecystectomy and side-to-side choledochoduodenostomy two years prior. Magnetic resonance cholangiopancreatography (MRCP) demonstrated persistent extrahepatic biliary ductal dilation with a fistulous tract from the proximal CBD to the proximal duodenum and edema along the pancreatic bed, suggesting pancreatitis (Figure 3). Endoscopic retrograde cholangiopancreatography (ERCP) revealed an opening at the second part of the duodenum, appearing classic for a functioning choleduodenal anastomosis. The ampulla of Vater was consistent with a prior sphincterotomy; the CBD was cannulated without stenting, and fibrous food debris was extracted until no evidence of filling defects remained. The findings were consistent with the sump syndrome. The patient’s post-operative course was unremarkable, and she was discharged home in stable condition.

Figure 3. Magnetic resonance cholangiopancreatography (MRCP) image findings.

Figure 3

The image demonstrates persistent extrahepatic biliary duct dilation with the fistulous tract from the common bile duct (CBD) to the proximal duodenum. (A: proximal CBD, B: fistulous connection, C: distal and obstructed CBD).

Discussion

A sump is a pit or reservoir serving as a liquid drain or receptacle [5]. In sump syndrome, a sump is formed as a complication of biliary bypass surgery, most commonly CDD, with an average timeframe to appear of 6 - 11 years postoperatively [6-12]. The resulting anatomy after a CDD creates a potential space for sump syndrome to develop (Figure 4). The incidence of sump syndrome following a CDD is variable, with reported values ranging from 0 - 15.7% [13,14]. This variation can be attributed partly to the length of time to presentation and the lack of a precise definition of the syndrome. Our patient presented two years after her CDD, making it an unusually early occurring case of sump syndrome.

Figure 4. Schematic representation of a choledochoduodenoanastomosis and “sump” formation.

Figure 4

Image credit: Daniel Wagner, who gave permission to publish with this article. 

A combination of clinical and radiologic findings best characterizes the sump syndrome. Though not always present, clinical symptoms are often recurrent and include right upper quadrant pain, jaundice, fever, liver abscesses, pancreatitis, and signs of cholangitis. Ultrasound, CT, and MRCP are all imaging modalities that can suggest sump syndrome. Radiological signs of suspicion include debris or gallstones in the distal CBD and pneumobilia [8]. Pneumobilia may indicate a functional anastomosis in a patient with an unknown surgical history. In a patient with a known history of CDD, this may be a normal finding. However, these radiographic findings warrant further investigation in conjunction with clinical symptoms or in a patient without detailed history. 

Despite clinical signs and symptoms indicative of sump syndrome, the diagnosis is confirmed with ERCP. Diagnosis and treatment may occur concomitantly because ERCP with sphincterotomy of the ampulla of Vater should be the first-line treatment in most instances of the syndrome [10,14,15]. In a large retrospective cohort study of 70 patients with a history of CDD, Demirel et al. found that endoscopic sphincterotomy successfully diagnosed and definitively treated all 11 with sump syndrome [14]. However, definitive surgery may be performed if endoscopic management fails or repeat intervention is required [6,16]. Recurrence of the syndrome after endoscopic sphincterotomy is not uncommon, as indicated by Mavrogiannis et al. In a case series of 31 patients, nearly 20% experienced restenosis of the sphincterotomy opening [15]. Surgical options are limited but include conversion to other biliary diversion options such as hepaticojejunostomy or distal gastrectomy with Roux-en-Y gastrojejunostomy [6,8].

Conclusions

It is essential to consider sump syndrome in patients with cholangitis or pancreatitis who have a history of biliary surgical intervention, especially when their procedural details are unknown. The case presented affirms MRCP as a valuable diagnostic tool for sump syndrome and is notable as an early-occurring example of a typically late-presenting complication of CDD. Identifying the diagnosis of sump syndrome is critical for definitive treatment and avoiding future episodes of potentially life-threatening complications like cholangitis.

Acknowledgments

The authors would like to thank Ann Harris for her assistance with the literature review.

Disclosures

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Author Contributions

Concept and design:  Daniel F. Wagner, Ross Driscoll, Leanne Sowunmi

Acquisition, analysis, or interpretation of data:  Daniel F. Wagner, Ross Driscoll, Leanne Sowunmi

Drafting of the manuscript:  Daniel F. Wagner

Critical review of the manuscript for important intellectual content:  Daniel F. Wagner, Ross Driscoll, Leanne Sowunmi

Supervision:  Ross Driscoll

References

  • 1.Biliary bypass redux: lessons for the therapeutic endoscopist from the archives of surgery. Rodrigues-Pinto E, Grimm IS, Baron TH. Gastrointest Endosc. 2017;85:428–432. doi: 10.1016/j.gie.2016.08.024. [DOI] [PubMed] [Google Scholar]
  • 2.Choledochoduodenostomy: is it really so bad? Leppard WM, Shary TM, Adams DB, Morgan KA. J Gastrointest Surg. 2011;15:754–757. doi: 10.1007/s11605-011-1465-2. [DOI] [PubMed] [Google Scholar]
  • 3.Choledochoduodenostomy, choledochojejunostomy or sphincteroplasty for biliary and pancreatic disease. Vogt DP, Hermann RE. Ann Surg. 1981;193:161–168. doi: 10.1097/00000658-198102000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Baron TH, Carr-Locke DL, Kozarek RA, Reddy N. Amsterdam: Elsevier; [ Jul; 2024 ]. 2024. ERCP, 4th Edition. [Google Scholar]
  • 5.Sump Definition & Meaning - Merriam-Webster. [ Dec; 2024 ]. 2024. https://www.merriam-webster.com/dictionary/sump https://www.merriam-webster.com/dictionary/sump
  • 6.Endoscopic management of sump syndrome after choledochoduodenostomy: retrospective analysis of 30 cases. Caroli-Bosc FX, Demarquay JF, Peten EP, et al. Gastrointest Endosc. 2000;51:180–183. doi: 10.1016/s0016-5107(00)70415-9. [DOI] [PubMed] [Google Scholar]
  • 7.Sump syndrome: a rare long-term complication of choledochoduodenostomy. Abraham H, Thomas S, Srivastava A. Case Rep Gastroenterol. 2017;11:428–433. doi: 10.1159/000477335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Don't forget about the sump! An uncommon complication many years after a choledochoduodenostomy. Chimal MF, Morales CE, Saucedo EM. Case Rep Gastroenterol. 2021;15:365–371. doi: 10.1159/000513397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Is it really sump syndrome? A case report. Suliman MS, Singh MM, Zaheer K, Malik SU, Abu-Hashyeh A. Cureus. 2019;11:0. doi: 10.7759/cureus.5837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Endoscopic sphincterotomy and surgical approaches in the treatment of the 'sump syndrome'. Marbet UA, Stalder GA, Faust H, Harder F, Gyr K. https://pmc.ncbi.nlm.nih.gov/articles/PMC1432981/ Gut. 1987;28:142–145. doi: 10.1136/gut.28.2.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hepatic abscess: a rare presentation of sump syndrome after choledochojejunostomy. Kim H, Triplett D, Kauffman S, Beck G. ACG Case Rep J. 2020;7:0. doi: 10.14309/crj.0000000000000447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sump syndrome: diagnosis dilemmas and therapeutic approaches-a case series. Abbarh S, Sawaf B, Almasri H, et al. Clin Case Rep. 2024;12:0. doi: 10.1002/ccr3.9378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Current assessment of choledochoduodenostomy: 130 consecutive series. Okamoto H, Miura K, Itakura J, Fujii H. Ann R Coll Surg Engl. 2017;99:545–549. doi: 10.1308/rcsann.2017.0082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.ERCP experience in patients with choledochoduodenostomy: diagnostic findings and therapeutic management. Demirel BT, Kekilli M, Onal IK, et al. Surg Endosc. 2011;25:1043–1047. doi: 10.1007/s00464-010-1313-6. [DOI] [PubMed] [Google Scholar]
  • 15.Sump syndrome: endoscopic treatment and late recurrence. Mavrogiannis C, Liatsos C, Romanos A, Goulas S, Dourakis S, Nakos A, Karvountzis G. Am J Gastroenterol. 1999;94:972–975. doi: 10.1111/j.1572-0241.1999.998_t.x. [DOI] [PubMed] [Google Scholar]
  • 16.Sump syndrome as a complication of choledochoduodenostomy. Qadan M, Clarke S, Morrow E, Triadafilopoulos G, Visser B. Dig Dis Sci. 2012;57:2011–2015. doi: 10.1007/s10620-011-2020-4. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES